Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Methods Mol Biol. 2022;2507:111-141. doi: 10.1007/978-1-0716-2368-8_7.
Structural and functional eukaryotic membrane protein research continues to grow at an increasing rate, placing greater significance on leveraging productive protein expression pipelines to feed downstream studies. Bacterial expression systems (e.g., E. coli) are often the preferred system due to their simple growth conditions, relative simplicity in experimental workflow, low overall cost per liter of cell growth, and ease of genetic manipulation. However, overproduction success of eukaryotic membrane proteins in bacterial systems is hindered by the limited native processing ability of bacterial systems for important protein folding interactions (e.g., disulfide bonds), post-translational modifications (e.g., glycosylation), and inherent disadvantages in protein trafficking and folding machinery compared to other expression systems.In contrast, Saccharomyces cerevisiae expression systems combine positive benefits of simpler bacterial systems with those of more complex eukaryotic systems (e.g., mammalian cells). Benefits include inexpensive growth, robust DNA repair and recombination machinery, amenability to high density growths in bioreactors, efficient transformation, and robust post-translational modification machinery. These characteristics make S. cerevisiae a viable first-alternative when bacterial overproduction is insufficient. Thus, this chapter provides a framework, using methods that have proven successful in prior efforts, for overproducing membrane anchored or membrane integrated proteins in S. cerevisiae. The framework is designed to improve yields for all levels of overexpression expertise, providing optimization insights for the variety of processes involved in heterologous protein expression.
真核生物膜蛋白的结构和功能研究持续以较高的速度增长,这使得利用高效的蛋白质表达体系来满足下游研究的需求变得尤为重要。由于细菌表达体系(如大肠杆菌)具有简单的生长条件、相对简单的实验工作流程、较低的每升细胞生长总成本以及易于进行基因操作等特点,因此通常是首选体系。然而,由于细菌体系对重要的蛋白质折叠相互作用(如二硫键)、翻译后修饰(如糖基化)的天然加工能力有限,以及与其他表达体系相比在蛋白质运输和折叠机制方面存在固有劣势,真核膜蛋白在细菌体系中的大量生产成功率受到了阻碍。相比之下,酿酒酵母表达体系将简单的细菌体系的优势与更复杂的真核体系(如哺乳动物细胞)的优势相结合。其优势包括廉价的生长、强大的 DNA 修复和重组机制、在生物反应器中进行高密度生长的适用性、高效的转化以及强大的翻译后修饰机制。这些特性使得酿酒酵母成为细菌过量生产不足时的可行替代方案。因此,本章提供了一个框架,使用在之前的努力中已被证明成功的方法,在酿酒酵母中过量生产膜锚定或膜整合蛋白。该框架旨在提高各级表达专家的产量,为异源蛋白表达涉及的各种过程提供优化见解。